Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and often debilitating side effect of cancer treatment, particularly associated with certain chemotherapeutic agents like taxanes and ...

BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Peripheral neuropathy is a troubling side effect of certain chemotherapy drugs, known as taxanes, that are commonly used to treat breast cancer. It often presents as tingling, numbness, pain, or ...

The compound was discovered and initially developed by Stony Brook University’s Iwao Ojima, PhD, and Martin Kaczocha, PhD.

The American Academy of Family Physicians recommends that peripheral neuropathy treatment address the underlying disease process, correct nutritional deficiencies, and aim to provide relief from ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

“Peripheral neuropathy is a degenerative disease, meaning it just keeps getting worse over time. We often associate it with diabetes, but there’s also chemotherapy-induced peripheral ...